Simcere Pharmaceutical Group Provides Notice of Annual General Meeting

_{//health-fitness.news-articles.net/content/2012/ .. p-provides-notice-of-annual-general-meeting.html}
^{Published in Health and Fitness on Friday, May 11th 2012 at 3:22 GMT by Market Wire}  

Simcere Pharmaceutical Group Provides Notice of Annual General Meeting -- NANJING, China, May 11, 2012 /PRNewswire-Asia/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about SCR

NANJING, China, May 11, 2012 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: [ SCR ]) ("Simcere" or the "Company"), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the annual general meeting of shareholders (the "Meeting") will be held on Friday, May 25, 2012 at 10 a.m.Beijing time. The meeting will be held at No.699-18, Xuanwu Avenue, Xuanwu District, Nanjing, the People's Republic of China.

The meeting's main purposes are:

1. To receive a report on the Company's operations.
2. To transact any other business properly brought before the Meeting.

All shareholders of record at the close of business on May 11, 2012 will be entitled to attend and vote at the Meeting, and at any adjournment or postponement thereof, or to appoint a proxy to attend and vote in his/her place. The proxy need not be a shareholder of the Company.

This notice and other information with regards to the Meeting are available on the investor relations section of the Company's website: [ www.simcere.com ].

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group ("Simcere") (NYSE: [ SCR ]) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, cardiovascular disease, infectious diseases and pain. For more information about Simcere Pharmaceutical Group, please visit [ www.simcere.com ].

SOURCE Simcere Pharmaceutical Group

RELATED LINKS
[ http://www.simcere.com ]